| __timestamp | ACADIA Pharmaceuticals Inc. | Taro Pharmaceutical Industries Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 32748000 | 91733000 |
| Thursday, January 1, 2015 | 90804000 | 87644000 |
| Friday, January 1, 2016 | 186456000 | 92365000 |
| Sunday, January 1, 2017 | 255062000 | 85656000 |
| Monday, January 1, 2018 | 265758000 | 88196000 |
| Tuesday, January 1, 2019 | 325638000 | 89971000 |
| Wednesday, January 1, 2020 | 388661000 | 93413000 |
| Friday, January 1, 2021 | 396028000 | 91355000 |
| Saturday, January 1, 2022 | 369090000 | 113676000 |
| Sunday, January 1, 2023 | 402466000 | 198366000 |
| Monday, January 1, 2024 | 218935000 |
Cracking the code
In the ever-evolving pharmaceutical industry, understanding financial trends is crucial. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of ACADIA Pharmaceuticals Inc. and Taro Pharmaceutical Industries Ltd. over the past decade. From 2014 to 2023, ACADIA's SG&A expenses surged by over 1,100%, peaking in 2023. In contrast, Taro's expenses grew by approximately 116% during the same period, with a notable spike in 2023. This divergence highlights ACADIA's aggressive expansion strategy compared to Taro's more conservative approach. Interestingly, 2024 data for ACADIA is missing, leaving room for speculation on future trends. As these companies navigate the competitive landscape, their SG&A expenses offer a window into their strategic priorities and market positioning.
Selling, General, and Administrative Costs: Insmed Incorporated vs ACADIA Pharmaceuticals Inc.
Breaking Down SG&A Expenses: Axsome Therapeutics, Inc. vs Taro Pharmaceutical Industries Ltd.
Cost Management Insights: SG&A Expenses for Alpine Immune Sciences, Inc. and ACADIA Pharmaceuticals Inc.
CymaBay Therapeutics, Inc. vs ACADIA Pharmaceuticals Inc.: SG&A Expense Trends
CRISPR Therapeutics AG or Taro Pharmaceutical Industries Ltd.: Who Manages SG&A Costs Better?
Comparing SG&A Expenses: PTC Therapeutics, Inc. vs Taro Pharmaceutical Industries Ltd. Trends and Insights
SG&A Efficiency Analysis: Comparing Veracyte, Inc. and ACADIA Pharmaceuticals Inc.
Comparing SG&A Expenses: ACADIA Pharmaceuticals Inc. vs Soleno Therapeutics, Inc. Trends and Insights
Cost of Revenue: Key Insights for ACADIA Pharmaceuticals Inc. and Taro Pharmaceutical Industries Ltd.
Who Optimizes SG&A Costs Better? MorphoSys AG or Taro Pharmaceutical Industries Ltd.
Vericel Corporation vs Taro Pharmaceutical Industries Ltd.: SG&A Expense Trends
Mesoblast Limited vs Taro Pharmaceutical Industries Ltd.: SG&A Expense Trends